A detailed history of Nuveen Asset Management, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 1,362,985 shares of ACAD stock, worth $23.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,362,985
Previous 441,849 208.47%
Holding current value
$23.4 Million
Previous $7.18 Million 192.14%
% of portfolio
0.01%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.14 - $19.14 $13.9 Million - $17.6 Million
921,136 Added 208.47%
1,362,985 $21 Million
Q2 2024

Aug 09, 2024

BUY
$14.62 - $18.42 $58,056 - $73,145
3,971 Added 0.91%
441,849 $7.18 Million
Q1 2024

May 13, 2024

BUY
$17.79 - $30.86 $370,138 - $642,073
20,806 Added 4.99%
437,878 $8.1 Million
Q4 2023

Feb 14, 2024

SELL
$20.78 - $31.77 $711,299 - $1.09 Million
-34,230 Reduced 7.58%
417,072 $13.1 Million
Q3 2023

Nov 14, 2023

SELL
$20.84 - $33.47 $4.99 Million - $8.02 Million
-239,664 Reduced 34.69%
451,302 $9.41 Million
Q2 2023

Aug 14, 2023

BUY
$17.8 - $25.65 $3.02 Million - $4.35 Million
169,717 Added 32.56%
690,966 $16.5 Million
Q1 2023

May 15, 2023

BUY
$16.32 - $20.92 $345,527 - $442,918
21,172 Added 4.23%
521,249 $9.81 Million
Q4 2022

Feb 14, 2023

SELL
$14.2 - $18.63 $6.09 Million - $7.99 Million
-428,896 Reduced 46.17%
500,077 $7.96 Million
Q3 2022

Nov 14, 2022

SELL
$14.11 - $18.27 $2.36 Million - $3.06 Million
-167,229 Reduced 15.26%
928,973 $15.2 Million
Q2 2022

Aug 15, 2022

BUY
$13.01 - $27.22 $2.79 Million - $5.83 Million
214,314 Added 24.3%
1,096,202 $15.4 Million
Q1 2022

May 16, 2022

BUY
$20.94 - $27.5 $6.02 Million - $7.91 Million
287,607 Added 48.4%
881,888 $22.5 Million
Q4 2021

Feb 14, 2022

BUY
$16.79 - $27.09 $815,742 - $1.32 Million
48,585 Added 8.9%
594,281 $13.2 Million
Q3 2021

Nov 12, 2021

SELL
$15.78 - $24.77 $6.96 Million - $10.9 Million
-440,806 Reduced 44.68%
545,696 $9.11 Million
Q2 2021

Aug 16, 2021

SELL
$19.4 - $27.42 $8.58 Million - $12.1 Million
-442,485 Reduced 30.96%
986,502 $24.1 Million
Q1 2021

May 17, 2021

SELL
$25.02 - $54.99 $689,801 - $1.52 Million
-27,570 Reduced 1.89%
1,428,987 $36.9 Million
Q4 2020

May 17, 2021

SELL
$41.04 - $56.79 $1.3 Million - $1.8 Million
-31,671 Reduced 2.13%
1,456,557 $77.9 Million
Q4 2020

Feb 16, 2021

SELL
$41.04 - $56.79 $3.86 Million - $5.34 Million
-94,051 Reduced 5.94%
1,488,228 $79.6 Million
Q3 2020

Nov 16, 2020

BUY
$36.42 - $57.0 $12.6 Million - $19.7 Million
344,846 Added 27.87%
1,582,279 $65.3 Million
Q2 2020

Aug 14, 2020

SELL
$39.26 - $52.73 $30.2 Million - $40.5 Million
-768,311 Reduced 38.31%
1,237,433 $60 Million
Q1 2020

May 14, 2020

SELL
$31.65 - $46.87 $6.05 Million - $8.96 Million
-191,174 Reduced 8.7%
2,005,744 $0
Q4 2019

Feb 14, 2020

BUY
$36.21 - $51.4 $23.3 Million - $33 Million
642,321 Added 41.32%
2,196,918 $94 Million
Q3 2019

Nov 14, 2019

SELL
$22.22 - $44.01 $740,059 - $1.47 Million
-33,306 Reduced 2.1%
1,554,597 $56 Million
Q2 2019

Aug 15, 2019

BUY
$23.32 - $28.12 $37 Million - $44.7 Million
1,587,903 New
1,587,903 $42.4 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.78B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.